Monte Rosa Therapeutics (GLUE)'s 30-day implied volatility (IV30) was 55.2% at the close on October 23, 2026, up from 54.8% the day before, against a 52-week range of 41.2% to 139.4%. Its 20-day historical volatility was 67.5%.
Data as of October 23, 2026.